Sloning BioTechnology, Pfizer enter into technology transfer deal
The deal covers the installation, training and use of Sloning’s technology platform Slonomics for fabrication of highly-diverse gene and protein libraries at Pfizer’s subsidiary Rinat Neuroscience. Under the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.